Abstract:Bicuspid aortic valve (BAV) is the most common congenital heart defect in human beings, with an estimated prevalence in the general population of between 0.5 and 2%. Moreover, BAV is the most common cause of aortic stenosis in the pediatric population. Patients with BAV may have no symptoms for life, and some of them may progress to aortic stenosis. Genetic factors increase the susceptibility and development of BAV. However, the pathogenesis and BAV are still unclear, and more genetic variants are still needed for elucidating the molecular mechanism and stratification of patients. The present study carried out screening of variants implicated in disease in BAV patients. The whole-exome sequencing (WES) was performed in 20 BAV patients and identified 40 different heterozygous missense mutations in 36 genes ( MIB2 , FAAH , S100A1 , RGS16 , MAP3K19 , NEB , TTN , TNS1 , CAND2 , CCK , KALRN , ATP10D , SLIT3 , ROS1 , FABP7 , NUP205 , IL11RA , NPR2 , COL5A1 , CUBN , JMJD1C , ANXA7 , TRIM8 , LGR4 , TPCN2 , APOA5 , GPR84 , LRP1 , NCOR2 , AKAP11 , ESRRB , NGB , AKAP13 , WWOX , KCNJ12 , ARHGEF1 ). The mutations in these genes were identified as recurrent variants implicated in disease by in silico prediction tool analysis. Nine genes (MIB2, S100A1, TTN, CCK, NUP205, LGR4, NCOR2, ESRRB, and WWOX) among the 36 genes were identified as variants implicated in disease via unanimous agreement of in silico prediction tool analysis and sequenced in an independent cohort of 137 BAV patients to validate the results of WES. BAV patients carrying these variants demonstrated reduced left ventricular ejection fractions (LVEF) (63.8 ± 7.5% vs. 58.4 ± 5.2%, P < 0.001) and larger calcification volume [(1129.3 ± 154) mm 3 vs. (1261.8 ± 123) mm 3 , P < 0.001]. The variants in TTN , NUP205 and NCOR2 genes are significantly associated with reduced LVEF, and the variants in S100A1 , LGR4 , ESRRB , and WWOX genes are significantly associated with larger calcification volume. We identified a panel of recurrent variants implicated in disease in genes related to the pathogenesis of BAV. Our data speculate that these variants are promising markers for risk stratification of BAV patients with increased susceptibility to aortic stenosis.

Analysis on mutational spectrum of GATA5 gene associated with bicuspid aortic valve

GATA 5 Loss-of-function Mutations Associated with Congenital Bicuspid Aortic Valve

Targeted Next-Generation Sequencing Identified ADAMTS5 As Novel Genetic Substrate in Patients with Bicuspid Aortic Valve.

GATA4 Loss-of-Function Mutation and the Congenitally Bicuspid Aortic Valve.

GATA6 Loss-of-function Mutation Contributes to Congenital Bicuspid Aortic Valve

[Novel GATA4 Mutations Identified in Patients with Congenital Atrial Septal Defects].

The c.1039 G>A single nucleotide polymorphisms in VEGFA gene are associated with the increased risk for bicuspid aortic valve

A Novel Gata4 Mutation Responsible for Congenital Ventricular Septal Defects

An Interesting Mybpc3 Heterozygous Mutation Associated with Bicuspid Aortic Valve

[A Novel GATA4 Mutation Leading to Congenital Ventricular Septal Defect].

Identification of the novel GATA6 mutation associated with congenital atrial septal defect

Mutation analysis of GATA4 gene in Han Chinese patients with atrioventricular septal defect

Elucidation of the genetic causes of bicuspid aortic valve disease

Identification of recurrent variants implicated in disease in bicuspid aortic valve patients through whole-exome sequencing

A Novel GATA4 Loss-of-Function Mutation Associated with Congenital Ventricular Septal Defect

A Novel GATA6 Mutation in Patients with Tetralogy of Fallot or Atrial Septal Defect

Genetic Screening for Novel GATA4 Mutations Associated with Congenital Atrial Septal Defect

A novel NKX2.5 loss-of-function mutation associated with congenital bicuspid aortic valve.

Genetic Research Progress of Bicuspid Aortic Valve and It's Clinical Significance

[Novel GATA4 Mutations Identified in Patients with Congenital Heart Disease].

The mutations ofGATA4andGATA6 in children with isolated atrial septal defect